Skip to main content

Table 3 Newcastle–Ottawa scale adapted for cross-sectional study

From: Malondialdehyde (MDA) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in ischemic stroke: a systematic review

No.

First author, year

Selection

Comparability

Outcome

Total

1

2

3

4

1

2

1.

Aygul, 2006 [13]

 

*

*

**

**

*

*

8

2.

Bir, 2006 [41]

 

*

*

**

**

*

*

8

3.

Demirkaya, 2001 [42]

 

*

*

**

**

*

*

8

4.

Dogan, 2018 [43]

 

*

*

**

**

*

*

8

5.

Haritha, 2020 [19]

 

*

*

**

**

*

*

8

6.

Moon, 2014 [44]

 

*

*

**

**

*

*

8

7.

Mueangson, 2020 [45]

 

*

*

**

**

*

*

8

8.

Sarkar, 2009 [46]

 

*

*

**

**

*

*

8

9.

Yildirim, 2007 [47]

 

*

*

**

**

*

*

8

  1. Maximum points for selection number 4, comparability, and outcome number 1 were 2
  2. Selection: (1) representativeness of the sample, (2) sample size, (3) non-respondents, (4) risk factor measurement tool
  3. Outcome: (1) assessment of the outcome, (2) statistical test
  4. The sign of * meant the point that each article was got